Alcohol biomarker screening in medical and surgical settings

Peter M. Miller, Claudia Spies, Tim Neumann, Martin A Javors, A. M. Hoyumpa, John D Roache, Amy Webb, Maryam Kashi, Francis E Sharkey, Raymond F. Anton, Brent M. Egan, Jan Basile, Shaun Nguyen, Michael F. Fleming, Kathryn Sullivan Dillie

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

Original languageEnglish (US)
Pages (from-to)185-193
Number of pages9
JournalAlcoholism: Clinical and Experimental Research
Volume30
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Biomarkers
Screening
Alcohols
Biopsy
Fatty Liver
Hepatitis C
Cost effectiveness
Liver
Cost-Benefit Analysis
Primary Health Care
Fibrosis
Hypertension
Inflammation
Wounds and Injuries
Serum
Therapeutics

Keywords

  • %CDT
  • Alcohol Biomarkers
  • GGT

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology

Cite this

Alcohol biomarker screening in medical and surgical settings. / Miller, Peter M.; Spies, Claudia; Neumann, Tim; Javors, Martin A; Hoyumpa, A. M.; Roache, John D; Webb, Amy; Kashi, Maryam; Sharkey, Francis E; Anton, Raymond F.; Egan, Brent M.; Basile, Jan; Nguyen, Shaun; Fleming, Michael F.; Dillie, Kathryn Sullivan.

In: Alcoholism: Clinical and Experimental Research, Vol. 30, No. 2, 02.2006, p. 185-193.

Research output: Contribution to journalArticle

Miller, PM, Spies, C, Neumann, T, Javors, MA, Hoyumpa, AM, Roache, JD, Webb, A, Kashi, M, Sharkey, FE, Anton, RF, Egan, BM, Basile, J, Nguyen, S, Fleming, MF & Dillie, KS 2006, 'Alcohol biomarker screening in medical and surgical settings', Alcoholism: Clinical and Experimental Research, vol. 30, no. 2, pp. 185-193. https://doi.org/10.1111/j.1530-0277.2006.00029.x
Miller, Peter M. ; Spies, Claudia ; Neumann, Tim ; Javors, Martin A ; Hoyumpa, A. M. ; Roache, John D ; Webb, Amy ; Kashi, Maryam ; Sharkey, Francis E ; Anton, Raymond F. ; Egan, Brent M. ; Basile, Jan ; Nguyen, Shaun ; Fleming, Michael F. ; Dillie, Kathryn Sullivan. / Alcohol biomarker screening in medical and surgical settings. In: Alcoholism: Clinical and Experimental Research. 2006 ; Vol. 30, No. 2. pp. 185-193.
@article{4cf5495a655d4603b5e1f4541def9a65,
title = "Alcohol biomarker screening in medical and surgical settings",
abstract = "This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of {\%}CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.",
keywords = "{\%}CDT, Alcohol Biomarkers, GGT",
author = "Miller, {Peter M.} and Claudia Spies and Tim Neumann and Javors, {Martin A} and Hoyumpa, {A. M.} and Roache, {John D} and Amy Webb and Maryam Kashi and Sharkey, {Francis E} and Anton, {Raymond F.} and Egan, {Brent M.} and Jan Basile and Shaun Nguyen and Fleming, {Michael F.} and Dillie, {Kathryn Sullivan}",
year = "2006",
month = "2",
doi = "10.1111/j.1530-0277.2006.00029.x",
language = "English (US)",
volume = "30",
pages = "185--193",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Alcohol biomarker screening in medical and surgical settings

AU - Miller, Peter M.

AU - Spies, Claudia

AU - Neumann, Tim

AU - Javors, Martin A

AU - Hoyumpa, A. M.

AU - Roache, John D

AU - Webb, Amy

AU - Kashi, Maryam

AU - Sharkey, Francis E

AU - Anton, Raymond F.

AU - Egan, Brent M.

AU - Basile, Jan

AU - Nguyen, Shaun

AU - Fleming, Michael F.

AU - Dillie, Kathryn Sullivan

PY - 2006/2

Y1 - 2006/2

N2 - This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

AB - This article highlights the proceedings of a symposium presented at the 28th Annual Meeting of the Research Society on Alcoholism in Santa Barbara, CA, on June 28, 2005, organized and chaired by Peter Miller. The presentations included (1) Screening for Alcohol Use Disorders in Surgical and Trauma Patients, presented by Claudia Spies; (2) Are Serum Levels of %CDT and GGT Related to Severity of Liver Biopsy Inflammation, Fibrosis, and Steatohepatitis in Patients with Hepatitis C? by Martin Javors; (3) Biochemical Alcohol Screening in the Treatment of Hypertension, presented by Peter Miller; and (4) The Cost-Effectiveness of a New Biomarker, CDT, in a Primary Care Sample, by Michael Fleming. Presentations were discussed by Raymond Anton.

KW - %CDT

KW - Alcohol Biomarkers

KW - GGT

UR - http://www.scopus.com/inward/record.url?scp=33644747401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644747401&partnerID=8YFLogxK

U2 - 10.1111/j.1530-0277.2006.00029.x

DO - 10.1111/j.1530-0277.2006.00029.x

M3 - Article

C2 - 16441267

AN - SCOPUS:33644747401

VL - 30

SP - 185

EP - 193

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 2

ER -